Auristone is an Asian-based epigenomic profiling company powered with data analytics capabilities and extensive epigenomic know-how. We use our comprehensive portfolio of Asian epigenomic database to power data-driven drug and biomarker discoveries. EPI-Call™ is our Flagship second generation Next Generation Sequencing (NGS) test. In addition to genomic information (DNA-seq), EPI-Call™ further provides epigenomic information around the tumour micro-environment and predicts patient response to immunotherapy. EPI-Call™ is the pragmatic choice to aid physicians in deciding the best treatment option for their patients. We are committed to supporting clinical and academic epigenomic research, and moving such research outcomes into the clinical setting. Driven by our aspiration to improve the quality of life for patients through better treatment, we are continuously seeking ways to bring our technologies to our clinical and academic partners. For more information on the company, drop us a line at enquiry@auristone.com or visit our website at www.auristone.com.
Location: Singapore
Employees: 1-10
Founded date: 2021
Investors 2
| Date | Name | Website |
| 13.04.2024 | Elev8.vc | elev8.vc |
| - | Genedant | genedant.c... |
Mentions in press and media 5
| Date | Title | Description |
| 10.02.2025 | To spur innovation in Singapore’s technology ecosystem, Elev8.vc closed $30 M deep tech fund | The latest $30 million fund from Singapore-based Elev8.vc, a venture capital firm that specializes in early-stage deep tech investments, has closed successfully. Elev8.vc is committed to fostering the next wave of technological innovation. ... |
| 28.01.2025 | Deals in brief: Elev8.vc closes USD 30 million fund, 129Knots raises funding, HongShan acquires majority stake in Marshall Group, and more | Elev8.vc closes USD 30 million deep tech fund Elev8.vc, a venture capital firm based in Singapore, has closed a USD 30 million fund targeting early-stage startups. The fund focuses on advancements in artificial intelligence, robotics, medte... |
| 03.04.2024 | SG biotech startup snags $4m seed funding from Elev8, Seeds Capital | InvestmentsNews Benjamin Cher · 1d ago · 2 min readSG biotech startup snags $4m seed funding from Elev8, Seeds Capital Photo credit: Shutterstock Biotech startup Auristone has secured a US$4 million seed funding round led by venture capital... |
| 02.04.2024 | Deals in brief: Alterno secures funding, Ant Group pumps SGD 200 million into Anext Bank, Carousell acquires LuxLexicon, and more | Alterno secures USD 1.5 million to cut carbon emissions in agriculture Alterno, a Vietnamese developer of sand batteries, has secured over USD 1.5 million in a seed funding round jointly led by The Radical Fund and Touchstone Partners, surp... |
| - | Auristone | “Providing actionable clinical insights with our epigenomics based workflows and know-how” |